NCT07706231

Brief Summary

This study will evaluate whether full-spectrum screen bar lighting can reduce eye fatigue and dry eye symptoms after a standardized screen task. Prolonged screen use is common in daily work and study and may cause blurred vision, eye soreness, dryness, headache, and reduced attention. Light environment may be one way to improve visual comfort during screen use, but more controlled clinical evidence is needed. In this randomized, parallel-group controlled study, 112 healthy adult participants will be assigned to either a full-spectrum screen bar lighting group or a brightness-matched control group without screen bar lighting. Participants in both groups will complete an approximately 2-hour standardized screen task in a controlled laboratory environment. The study will compare changes before and after the task in objective and subjective measures of visual fatigue and dry eye, including critical flicker fusion frequency, visual fatigue questionnaire scores, eye movement and blinking parameters, pupil parameters, tear film-related measurements, and dry eye symptom scores. Safety and discomfort during the study will also be recorded.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
5mo left

Started Jul 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress8%
Jul 2026Dec 2026

First Submitted

Initial submission to the registry

July 9, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 15, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

July 20, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

July 22, 2026

Status Verified

July 1, 2026

Enrollment Period

5 months

First QC Date

July 9, 2026

Last Update Submit

July 20, 2026

Conditions

Keywords

Visual fatigueDry EyeComputer vision syndromeCritical flicker fusion frequencyFull-spectrum

Outcome Measures

Primary Outcomes (1)

  • Change in Critical Flicker Fusion Frequency

    Critical flicker fusion frequency (CFF) will be measured in Hz using the Handy Flicker HF-III device. The outcome will be calculated as the post-task CFF value minus the baseline CFF value. This measure will be used as an objective indicator of visual fatigue after the standardized screen task.

    Baseline and immediately after completion of the approximately 2-hour standardized screen task

Secondary Outcomes (4)

  • Change in Computer Vision Syndrome Questionnaire Score

    Baseline and immediately after completion of the approximately 2-hour standardized screen task

  • Change in EyeFatigue Tracker Ocular Behavioral Parameters

    Baseline and immediately after completion of the approximately 2-hour standardized screen task

  • Change in Keratograph 5M Ocular Surface Assessment

    Baseline and immediately after completion of the approximately 2-hour standardized screen task

  • Change in Eye Dryness Score on the 0-100 Visual Analog Scale

    Baseline and immediately after completion of the approximately 2-hour standardized screen task

Study Arms (2)

Full-Spectrum Screen Bar Lighting

EXPERIMENTAL

Participants assigned to this arm will complete an approximately 2-hour standardized screen task in a controlled laboratory environment using a full-spectrum screen bar light (MB23001032H-1B) as task lighting. The screen task may include computer-based text processing, screen reading, or viewing specified video materials. Task content, duration, and completion requirements will be kept consistent with the control arm.

Device: Full-spectrum screen bar light

Brightness-Matched Control

PLACEBO COMPARATOR

Participants assigned to this arm will complete the same approximately 2-hour standardized screen task in the same controlled laboratory environment without using a full-spectrum screen bar light or any additional screen bar lighting. Screen brightness will be adjusted to match the brightness condition of the full-spectrum screen bar lighting arm. Task content, duration, and completion requirements will be kept consistent with the experimental arm.

Other: Brightness-matched screen task without screen bar lighting

Interventions

The full-spectrum screen bar light will be used as task lighting during an approximately 2-hour standardized screen task in a controlled laboratory environment. Participants will complete computer-based text processing, screen reading, or viewing of specified video materials to simulate prolonged near-screen use.

Full-Spectrum Screen Bar Lighting

Participants will complete the standardized screen task without using a screen bar light. Screen brightness will be adjusted to match the brightness condition of the full-spectrum screen bar lighting arm. The task type, content, duration, and completion requirements will be the same as those in the experimental arm.

Brightness-Matched Control

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18 to 35 years, male or female.
  • Average daily electronic screen exposure of at least 4 hours.
  • Near visual acuity at 40 cm of 0.5 or better, and able to complete the study 1. tasks and measurements stably.
  • Able and willing to provide written informed consent.

You may not qualify if:

  • Presence of ocular inflammation or ocular disease.
  • History of severe systemic disease, neurological disease, or psychiatric disorder.
  • Pregnancy or lactation.
  • Use of dry eye or visual fatigue treatments, or contact lens wear, within 1 month before the study.
  • History of ocular surgery within the past 6 months.
  • Daily use of lenses with blue-light blocking, photochromic, polarized, filtering, or similar optical functions.
  • Professional background in ophthalmology or optical products.
  • Intake of caffeine or other stimulants within 4 hours before the study.
  • Best-corrected visual acuity (BCVA) less than 0.8.
  • Anisometropia of 1.00 diopter or greater, or astigmatism of ±2.00 diopters or greater.
  • Intraocular pressure (IOP) less than 5 mmHg or greater than 21 mmHg.
  • Non-invasive tear breakup time (NIBUT) less than 5 seconds in either eye.
  • Ocular Surface Disease Index (OSDI) score of 33 or greater.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan Ophthalmic Center

Guangzhou, Guangdong, 510060, China

Location

Related Publications (4)

  • Chen H, Ratanapakorn T, Sukonpatip M, Asawaphureekorn S, Thinkhamrop W, Wang X, Eungpinichpong W. Effects of yoga facial massage on computer vision syndrome and ocular motor function: A randomised controlled trial. Complement Ther Med. 2025 Dec;95:103270. doi: 10.1016/j.ctim.2025.103270. Epub 2025 Oct 22.

    PMID: 41135797BACKGROUND
  • Ide T, Toda I, Miki E, Tsubota K. Effect of Blue Light-Reducing Eye Glasses on Critical Flicker Frequency. Asia Pac J Ophthalmol (Phila). 2015 Mar-Apr;4(2):80-5. doi: 10.1097/APO.0000000000000069.

    PMID: 26065349BACKGROUND
  • Singh S, Downie LE, Anderson AJ. Do Blue-blocking Lenses Reduce Eye Strain From Extended Screen Time? A Double-Masked Randomized Controlled Trial. Am J Ophthalmol. 2021 Jun;226:243-251. doi: 10.1016/j.ajo.2021.02.010. Epub 2021 Feb 12.

    PMID: 33587901BACKGROUND
  • Lin JB, Gerratt BW, Bassi CJ, Apte RS. Short-Wavelength Light-Blocking Eyeglasses Attenuate Symptoms of Eye Fatigue. Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):442-447. doi: 10.1167/iovs.16-20663.

    PMID: 28118668BACKGROUND

MeSH Terms

Conditions

AsthenopiaDry Eye Syndromes

Condition Hierarchy (Ancestors)

Eye DiseasesLacrimal Apparatus Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 9, 2026

First Posted

July 15, 2026

Study Start

July 20, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

July 22, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations